Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Oxygen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Solitary Pulmonary Nodule 2 Multiple Pulmonary Nodules 2 Lung Neoplasms 2 Surgical Wound Infection 1 Skin Neoplasms 1 Pulmonary Atelectasis 1 Postoperative Complications 1 Neoplasms 1 Melanoma 1 Hypoxia 1 Hematologic Neoplasms 1 Brain Neoplasms 1

Interventions

fluoroazomycin arabinoside 3 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 Propofol 2 gadobutrol 1 Sevoflurane 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Furosemide 1 Exercise 1 Diagnostic Imaging 1 Blood Specimen Collection 1 Biopsy 1 4-methylbenzenesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04566419 2022-09-16

SAMURAI

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Completed

Hypoxia, Pulmonary Atelectasis, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡